Role of fragile X mental retardation protein in chronic pain

5Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chronic pain has detrimental effects on one’s quality of life. However, its treatment options are very limited, and its underlying pathogenesis remains unclear. Recent research has suggested that fragile X mental retardation protein is involved in the development of chronic pain, making it a potential target for prevention and treatment. The current review of literature will examine the function of fragile X mental retardation protein and its associated pathways, through which we hope to gain insight into how fragile X mental retardation protein may contribute to nociceptive sensitization and chronic pain.

Cite

CITATION STYLE

APA

Mei, X., Yang, Y., Zhao, J., Wang, Y., Chen, Q. L., Qian, X., … Feng, Z. (2020). Role of fragile X mental retardation protein in chronic pain. Molecular Pain. SAGE Publications Inc. https://doi.org/10.1177/1744806920928619

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free